Treatment of Takayasu's arteritis with tumor necrosis factor antagonists.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18718263.
- Also identified by DOI 10.1016/j.jpeds.2008.04.049.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Four children with Takayasu's arteritis were treated with tumor necrosis factor antagonists because of disease relapse during conventional therapy or as a first-line agent. Two patients went into remission; in the other 2, the response was partial. Anti-tumor necrosis factor agents can have a role in the treatment of Takayasu's arteritis; further controlled studies are required.
Medical subject headings
- Anti-Inflammatory Agents
- Antibodies, Monoclonal
- Takayasu Arteritis
- Tumor Necrosis Factor-alpha